{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:21:15Z","timestamp":1794853275612,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104906","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T21:32:55Z","timestamp":1597354375000},"page":"104906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods"],"prefix":"10.1016","volume":"182","author":[{"given":"Mira C.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliy P.","family":"Mishin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"De La Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Chesnokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-1725","authenticated-orcid":false,"given":"Malania M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-4282","authenticated-orcid":false,"given":"Rebecca J.G.","family":"Kondor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-980X","authenticated-orcid":false,"given":"David E.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa V.","family":"Gubareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104906_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104906_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2020.104906_bib3","first-page":"367","article-title":"Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir","volume":"221","author":"Chesnokov","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.01417-09","article-title":"Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing","volume":"54","author":"Deyde","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104906_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2008.08.008","article-title":"Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses","volume":"81","author":"Deyde","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104906_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib7","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1128\/JVI.03193-13","article-title":"Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?","volume":"88","author":"Dimmock","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104906_bib8","doi-asserted-by":"crossref","first-page":"1800666","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800666","article-title":"Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016\/17 and 2017\/18 seasons","volume":"24","author":"Gubareva","year":"2019","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2020.104906_bib9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.5858\/arpa.2012-0463-RA","article-title":"Fundamentals of pyrosequencing","volume":"137","author":"Harrington","year":"2013","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.antiviral.2020.104906_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104906_bib11","article-title":"Baloxavir marboxil in Japanese pediatric patients with influenza: safety and clinical and virologic outcomes","author":"Hirotsu","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41564-019-0609-0","article-title":"Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets","volume":"5","author":"Imai","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.antiviral.2020.104906_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa164","article-title":"Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil","author":"Ince","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3201\/eid2407.180028","article-title":"Mapping of the US domestic influenza virologic surveillance landscape","volume":"24","author":"Jester","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib15","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1073\/pnas.1916825117","article-title":"Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility","volume":"117","author":"Jones","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104906_bib16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/irv.12725","article-title":"A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA\/I38X amino acid substitutions","volume":"14","author":"Koszalka","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.antiviral.2020.104906_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2019.02.007","article-title":"Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018","volume":"164","author":"Koszalka","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104906_bib18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1128\/JCM.02424-10","article-title":"Detection of hemagglutinin variants of the pandemic influenza A(H1N1) 2009 virus by pyrosequencing","volume":"49","author":"Levine","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104906_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/irv.12728","article-title":"Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil","volume":"14","author":"Nakauchi","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.antiviral.2020.104906_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jmv.22101","article-title":"Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A\/H1N1 2009 virus by duplex one-step RT-PCR assay","volume":"83","author":"Nakauchi","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104906_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","article-title":"In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit","volume":"160","author":"Noshi","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104906_bib22","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104906_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12859-016-0976-y","article-title":"Illumina error profiles: resolving fine-scale variation in metagenomic sequencing data","volume":"17","author":"Schirmer","year":"2016","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.antiviral.2020.104906_bib24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12864-016-3030-6","article-title":"Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assembler","volume":"17","author":"Shepard","year":"2016","journal-title":"BMC Genom."},{"key":"10.1016\/j.antiviral.2020.104906_bib25","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1128\/JVI.00832-13","article-title":"Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease","volume":"87","author":"Stevaert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104906_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3201\/eid1802.111466","article-title":"Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11","volume":"18","author":"Storms","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3201\/eid2511.190757","article-title":"Human-to-Human transmission of influenza A(H3N2) virus with reduced susceptibility to baloxavir, Japan, February 2019","volume":"25","author":"Takashita","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib28","doi-asserted-by":"crossref","first-page":"1900170","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900170","article-title":"Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2020.104906_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.antiviral.2020.104906_bib30","first-page":"346","article-title":"Treatment-Emergent influenza variant viruses with reduced baloxavir susceptibility: impact on clinical and virologic outcomes in uncomplicated influenza","volume":"221","author":"Uehara","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104906_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.mimet.2012.03.012","article-title":"High-throughput species identification of enterococci using pyrosquencing","volume":"89","author":"Zaheer","year":"2012","journal-title":"J. Microbiol. Methods"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422030320X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635422030320X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:44Z","timestamp":1759062824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635422030320X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":31,"alternative-id":["S016635422030320X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104906","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104906"}}